PURPOSE: To characterize the effects of P2X(7) purinergic receptors on lacrimal gland function. METHODS: P2X(7) purinergic receptors were identified by RT-PCR, Western blot analysis, and immunofluorescence techniques. Rat lacrimal gland acini were isolated by collagenase digestion. Acini were incubated with the fluorescent indicator molecule fura 2, and [Ca(2+)](i) was measured by a fluorescence imaging system. Protein secretion was measured with a fluorescence assay system. Activation of ERK 1/2 was determined by Western blot analysis with an antibody against phosphorylated (active) ERK 1/2. RESULTS: P2X(7) receptors were present in the lacrimal gland by RT-PCR and Western blot analysis. These receptors were located in the membranes of acinar and ductal cells and the cytoplasm of acinar cells. Activation of P2X(7) receptors with (benzoylbenzoyl)adenosine 5'-triphosphate increased [Ca(2+)](i), peroxidase secretion, and ERK 1/2 activation, each of which was inhibited by the P2X(7) receptor inhibitors Brilliant Blue G or A 438079. CONCLUSIONS: P2X(7) purinergic receptors are present in rat lacrimal gland and when stimulated increase [Ca(2+)](i), protein secretion, and ERK 1/2 activation.
PURPOSE: To characterize the effects of P2X(7) purinergic receptors on lacrimal gland function. METHODS: P2X(7) purinergic receptors were identified by RT-PCR, Western blot analysis, and immunofluorescence techniques. Rat lacrimal gland acini were isolated by collagenase digestion. Acini were incubated with the fluorescent indicator molecule fura 2, and [Ca(2+)](i) was measured by a fluorescence imaging system. Protein secretion was measured with a fluorescence assay system. Activation of ERK 1/2 was determined by Western blot analysis with an antibody against phosphorylated (active) ERK 1/2. RESULTS: P2X(7) receptors were present in the lacrimal gland by RT-PCR and Western blot analysis. These receptors were located in the membranes of acinar and ductal cells and the cytoplasm of acinar cells. Activation of P2X(7) receptors with (benzoylbenzoyl)adenosine 5'-triphosphate increased [Ca(2+)](i), peroxidase secretion, and ERK 1/2 activation, each of which was inhibited by the P2X(7) receptor inhibitors Brilliant Blue G or A 438079. CONCLUSIONS: P2X(7) purinergic receptors are present in rat lacrimal gland and when stimulated increase [Ca(2+)](i), protein secretion, and ERK 1/2 activation.
Authors: Robin R Hodges; Marie A Shatos; Rachel S Tarko; Joanna Vrouvlianis; Jian Gu; Darlene A Dartt Journal: Invest Ophthalmol Vis Sci Date: 2005-08 Impact factor: 4.799
Authors: Galina V Jerdeva; Kaijin Wu; Francie A Yarber; Christopher J Rhodes; Daniel Kalman; Joel E Schechter; Sarah F Hamm-Alvarez Journal: J Cell Sci Date: 2005-10-15 Impact factor: 5.285
Authors: Simon R J Taylor; Mireya Gonzalez-Begne; Stephen Dewhurst; Giovanna Chimini; Christopher F Higgins; James E Melvin; James I Elliott Journal: J Immunol Date: 2008-01-01 Impact factor: 5.422
Authors: Julie Sanderson; Darlene A Dartt; Vickery Trinkaus-Randall; Jesus Pintor; Mortimer M Civan; Nicholas A Delamere; Erica L Fletcher; Thomas E Salt; Antje Grosche; Claire H Mitchell Journal: Exp Eye Res Date: 2014-08-20 Impact factor: 3.467
Authors: Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn Journal: Ocul Surf Date: 2017-07-20 Impact factor: 5.033
Authors: Kaori Ohtomo; Marie A Shatos; Joanna Vrouvlianis; Dayu Li; Robin R Hodges; Darlene A Dartt Journal: Invest Ophthalmol Vis Sci Date: 2011-12-16 Impact factor: 4.799